A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults
Clinical trial NCT07510529 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07510529
- Sponsor
- Simcere Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2026-05-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.